Bio News
Illumina has launched the MiSeq i100 Series-CN in China, completing sequencing in as little as 2.5 hours. The company recently delivered the first units manufactured at its Chinese production facility to customers. Illumina plans to target the Chinese market with the localized product, which uses 1,000-cycle reagents, for applications including antibody discovery and quality control.
BIOBOOK TEAM
biobookmedia@biobook.co.krIpscell Receives Notice of Allowance for Universal iPSC Patent, Strengthening Cell Line Supply Business
Ministry of Trade, Industry and Energy and Ministry of Food and Drug Safety Sign Agreement on AI Transformation and Global Competitiveness in Biotech
Paragon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
